310 related articles for article (PubMed ID: 29954598)
1. Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome.
Leccese P; Ozguler Y; Christensen R; Esatoglu SN; Bang D; Bodaghi B; Celik AF; Fortune F; Gaudric J; Gül A; Kötter I; Mahr A; Moots RJ; Richter J; Saadoun D; Salvarani C; Scuderi F; Sfikakis PP; Siva A; Stanford M; Tugal-Tutkun I; West R; Yurdakul S; Olivieri I; Yazici H; Hatemi G
Semin Arthritis Rheum; 2019 Feb; 48(4):752-762. PubMed ID: 29954598
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for Behcet's syndrome.
Saenz A; Ausejo M; Shea B; Wells G; Welch V; Tugwell P
Cochrane Database Syst Rev; 2000; 1998(2):CD001084. PubMed ID: 10796413
[TBL] [Abstract][Full Text] [Related]
3. 2018 update of the EULAR recommendations for the management of Behçet's syndrome.
Hatemi G; Christensen R; Bang D; Bodaghi B; Celik AF; Fortune F; Gaudric J; Gul A; Kötter I; Leccese P; Mahr A; Moots R; Ozguler Y; Richter J; Saadoun D; Salvarani C; Scuderi F; Sfikakis PP; Siva A; Stanford M; Tugal-Tutkun I; West R; Yurdakul S; Olivieri I; Yazici H
Ann Rheum Dis; 2018 Jun; 77(6):808-818. PubMed ID: 29625968
[TBL] [Abstract][Full Text] [Related]
4. Apremilast in Refractory Behçet's Syndrome: A Multicenter Observational Study.
Vieira M; Buffier S; Vautier M; Le Joncour A; Jamilloux Y; Gerfaud-Valentin M; Bouillet L; Lazaro E; Barete S; Misery L; Gobert D; Goulenok T; Fain O; Sacre K; Sève P; Cacoub P; Comarmond C; Saadoun D
Front Immunol; 2020; 11():626792. PubMed ID: 33613571
[TBL] [Abstract][Full Text] [Related]
5. Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.
Ozguler Y; Leccese P; Christensen R; Esatoglu SN; Bang D; Bodaghi B; Çelik AF; Fortune F; Gaudric J; Gul A; Kötter I; Mahr A; Moots RJ; Richter J; Saadoun D; Salvarani C; Scuderi F; Sfikakis PP; Siva A; Stanford M; Tugal-Tutkun I; West R; Yurdakul S; Olivieri I; Yazici H; Hatemi G
Rheumatology (Oxford); 2018 Dec; 57(12):2200-2212. PubMed ID: 30107448
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of apremilast for the treatment of adult patients with oral ulcers associated with Behçet's syndrome.
Özdede A; Hatemi G
Expert Opin Pharmacother; 2021 Aug; 22(12):1533-1537. PubMed ID: 34218739
[TBL] [Abstract][Full Text] [Related]
7. Trial of Apremilast for Oral Ulcers in Behçet's Syndrome.
Hatemi G; Mahr A; Ishigatsubo Y; Song YW; Takeno M; Kim D; Melikoğlu M; Cheng S; McCue S; Paris M; Chen M; Yazici Y
N Engl J Med; 2019 Nov; 381(20):1918-1928. PubMed ID: 31722152
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature.
Hatemi I; Hatemi G; Pamuk ON; Erzin Y; Celik AF
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S129-37. PubMed ID: 26486925
[TBL] [Abstract][Full Text] [Related]
9. Behçet's syndrome: facts and controversies.
Mat C; Yurdakul S; Sevim A; Özyazgan Y; Tüzün Y
Clin Dermatol; 2013; 31(4):352-361. PubMed ID: 23806152
[TBL] [Abstract][Full Text] [Related]
10. Update on the treatment of Behçet's syndrome.
Esatoglu SN; Hatemi G
Intern Emerg Med; 2019 Aug; 14(5):661-675. PubMed ID: 30684097
[TBL] [Abstract][Full Text] [Related]
11. Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease.
Hatemi G; Silman A; Bang D; Bodaghi B; Chamberlain AM; Gul A; Houman MH; Kötter I; Olivieri I; Salvarani C; Sfikakis PP; Siva A; Stanford MR; Stübiger N; Yurdakul S; Yazici H
Ann Rheum Dis; 2009 Oct; 68(10):1528-34. PubMed ID: 18420940
[TBL] [Abstract][Full Text] [Related]
12. [An update on Behçet's syndrome].
Xenitidis T; Henes JC
Laryngorhinootologie; 2024 May; 103(5):352-357. PubMed ID: 38330997
[TBL] [Abstract][Full Text] [Related]
13. SER recommendations on treatment of refractory Behçet's syndrome.
Moriano Morales C; Graña Gil J; Brito García N; Martín Varillas JL; Calvo Del Río V; Moya Alvarado P; Narváez García FJ; Espinosa G; Díaz Del Campo Fontecha P; Guerra Rodríguez M; Mateo Arranz J; López Gómez M; Francisco Hernández FM; Trujillo MM; Dos Santos Sobrín R; Martín Sánchez JI; Maese Manzano J; Suárez Cuba J
Reumatol Clin (Engl Ed); 2024 Apr; 20(4):204-217. PubMed ID: 38614885
[TBL] [Abstract][Full Text] [Related]
14. [Progress in interferon: A treatment of Behcet syndrome].
Yan D; Zheng WJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1166-1170. PubMed ID: 33331331
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet's disease: A systematic review and meta-analysis.
Iizuka Y; Takase-Minegishi K; Hirahara L; Kirino Y; Soejima Y; Namkoong HO; Horita N; Yoshimi R; Takeuchi M; Takeno M; Mizuki N; Nakajima H
Mod Rheumatol; 2022 Oct; 32(6):1153-1162. PubMed ID: 34752620
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
Hu YC; Yang YH; Lin YT; Wang LC; Yu HH; Lee JH; Chiang BL
BMC Pediatr; 2019 Jul; 19(1):232. PubMed ID: 31296171
[TBL] [Abstract][Full Text] [Related]
17. Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.
Melikoglu M; Fresko I; Mat C; Ozyazgan Y; Gogus F; Yurdakul S; Hamuryudan V; Yazici H
J Rheumatol; 2005 Jan; 32(1):98-105. PubMed ID: 15630733
[TBL] [Abstract][Full Text] [Related]
18. Behçet's syndrome. The Cerrahpasa experience. Members of the Behçet's Syndrome Research Centre.
Yazici H; Fresko I; Hamuryudan V; Mat C; Melikoglu M; Ozyazgan Y; Tuzun Y; Yurdakul S
Adv Exp Med Biol; 1999; 455():135-40. PubMed ID: 10599334
[TBL] [Abstract][Full Text] [Related]
19. Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.
Hatemi G; Melikoglu M; Tunc R; Korkmaz C; Turgut Ozturk B; Mat C; Merkel PA; Calamia KT; Liu Z; Pineda L; Stevens RM; Yazici H; Yazici Y
N Engl J Med; 2015 Apr; 372(16):1510-8. PubMed ID: 25875256
[TBL] [Abstract][Full Text] [Related]
20. Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement.
Mangelsdorf HC; White WL; Jorizzo JL
J Am Acad Dermatol; 1996 May; 34(5 Pt 1):745-50. PubMed ID: 8632067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
